follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeHealthBiotechnology

      Biotechnology

      The biotechnology sector focuses on developing drugs predominantly for the Healthcare sector. 

      These companies make products from living organisms such as plant life and,  through biotechnology, are developing treatment or cures for a specific ailment.

      Examples of biotechnology companies include AVEO, Aeterna Zentaris, and Sorrento Therapeutics.

      Biotechnology

      Diffusion Pharmaceuticals Presents TSC Candidate at Biotech Conference, Stock Climbs 35%

      Jan 9 Samara Malkin
      Diffusion Pharmaceuticals Inc. (NASDAQCM:DFFN) has experienced a stock increase of 35% today on the Nasdaq Capital Market. At the time of writing, the stock has moved $0.43, from the previous closing price of $1.21 to ... [Read]
      Biotechnology

      Should You Be Investing in Biotech Stocks? Pain Therapeutics Up 150% and GT Biopharma Up Nearly 15%

      Jan 9 Caroline Harris
      What a way to start off the week! If you’re an investor, and you’re looking to spice up your investment portfolio, why not invest in some biotech stocks? Considering the industry has been doing quite ... [Read]
      Biotechnology

      Should you Buy Codexis Despite Lofty Valuations?

      Jan 8 Siraj Sarwar
      Codexis Inc. (NASDAQ:CDXS) has stunned investors with the massive growth of 68% in the last twelve months, soaring significantly by 213% in the last five years. CDXS stock is currently trading around $8.5 a share, ... [Read]
      Biotechnology

      Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.

      Jan 8 Chelsea Roh
      Switzerland-based Axovant Sciences Ltd (NASDAQ:AXON) shares have plummeted over 50% today as it announces it has scrapped its program and experiments for curing a type of dementia. The drug was called intrepirdine and it has ... [Read]
      Ohr Pharmaceuticals
      Biotechnology

      Ohr Pharmaceutical Experiences Disappointing 80% Drop in Stock After Reporting Even More Disappointing Test Results

      Jan 5 Samara Malkin
      Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) disappoints this week, the stock dropping over 80% – a complete one-eighty from many other biotech companies that have been soaring this week. Ohr Pharmaceutical stock experienced a drop of $1.6462, ... [Read]
      Biotechnology

      TiGenix to be Acquired by Takeda Pharmaceutical, Stocks Soars by 70%

      Jan 5 Samara Malkin
      TiGenix (NASDAQ:TIG) has joined the ranks of the biotech companies seeing stocks soar this week. The company is a biopharmaceutical company that exploits anti-inflammatory properties of stem cells to develop therapies for serious medical conditions ... [Read]
      Biotechnology

      Another Successful Healthcare Company: ChemoCentryx, Up 35%

      Jan 4 Samara Malkin
      The stock for ChemoCentryx Inc. (NASDAQ:CCXI) is on the rise, in the form of a 35% increase. This is only some of the good news for the company, which has just received two massive milestone ... [Read]
      Ampliphi Biosciences Corp
      Biotechnology

      Biotechnology Stocks On The Rise, Ampliphi Biosciences Corp Makes A 16% Rally After Clinical Treatment Success

      Jan 4 Chelsea Roh
      Biotechnology stocks are doing extremely well on the exchanges today, as a few biotech companies around the world announced clinical trial successes this morning. AmpliPhi Biosciences Corp. (AMX:APHB) has shown a large rally, as the ... [Read]
      Stem cell breakthrough
      Biotechnology

      Successful Stem Cell Breakthrough Launches Cellect Biotechnology Ltd Stock Up Nearly 50%

      Jan 4 Chelsea Roh
      Cellect Biotechnology Ltd. (NASDAQ:APOP) is having a great start on the trading floor this morning after announcing the breakthrough results of its clinical stem cell trial. The Israeli based company has stated that it has ... [Read]
      Spark Therapeutics
      Biotechnology

      Spark Therapeutics Prices Genetic Treatment at $850,000 and Stock Still Managed to Climb

      Jan 3 Samara Malkin
      Spark Therapeutics Inc. (NASDAQ:ONCE) has finally released the price of its much-anticipated gene-therapy treatment for a rare form of genetic blindness and, while the price is lower than originally expected, it’s still a mighty steep ... [Read]

      Posts pagination

      « 1 … 24 25 26 … 32 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767